However, the RCT studies, case reports, and the FAERS database case all highlighted that we should be aware of co-administered neuropsychotropic drugs that may associated with SSIBs
Mansur RB, Zugman A, Ahmed J, et al
23 in partial Asian regions), is a manifestation of metabolic disorders and can constitute one of the diagnostic criteria for MASLD
Microdosing GLP-1 for autoimmune conditions is an emerging area of interest, with some practitioners maintaining patients on very low doses primarily for anti-inflammatory benefits rather than weight management
Its a very useful test but its not perfect, and thats why its not always relied upon alone
One of the most debilitating and defining hallmarks of ME/CFS and Long COVID is post-exertional malaise (PEM), a severe, disproportionate exacerbation of symptoms following even minor physical, cognitive, or emotional exertion